Novel norditerpene-phenanthrenes from Selaginella effusa inhibit T24 cell proliferation via blockade of the TRPV1/ STAT3/NF-κB pathway
Fitoterapia · 2026
DOI: 10.1016/j.fitote.2025.106986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fitoterapia, 2026. Verfasst von Wen-Tao Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry a…. Hauptthemen laut MEDLINE: Phenanthrenes, Selaginellaceae, Antineoplastic Agents, Phytogenic, Diterpenes. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Higher Education Discipline Innovation Project, National Natural Science Foundation of China, Guangxi Natural Science Foundation.
Abstract (Originalsprache)
Ten novel norditerpene-phenanthrenes (1-10) and two new analogs (11-12) were isolated from Selaginella effusa. Their structures and absolute configuration were established by HRESIMS; IR, UV, 1D and 2D NMR spectroscopy; X-ray crystallography; and ECD. The antiproliferative effects of these compounds were evaluated in T24 cells via the MTT method and compound 1 exhibited the greatest antitumor activity, with an IC50 value of 3.21 μM. A mechanistic study revealed that compound 1 inhibited not only T24 cell proliferation but also the TRPV1 ionchannel. Mechanistically, compound 1 induces cell damage and cell cycle arrest by downregulating PARP1, CDK2 and Cyclin E1 by modulating STAT3-mediated signaling pathways in T24 cells. Compound 1 also regulates NF-κB-mediated signaling in T24 cells, decreases ther mitochondrial membrane potential, and increases the level of mitochondrial reactive oxygen species, thereby inducing cell apoptosis. In addition, compound 1 also showed the potential to inhibit MMP-9 and N-cadherin, thereby suppressing cancer cell proliferation and migration. These findings suggest that compound 1 might be a potential lead compound for chemotherapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources & University Engineeri…
- Scientific Experiment Center, Guilin Medical university, Guilin 541199, china.
- Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes With Drug Resistance, Youjiang Medical University for Nationalities, Baise 533000, China.
Förderung
- Higher Education Discipline Innovation Project
- National Natural Science Foundation of China
- Guangxi Natural Science Foundation
Zitieren
APA
Sun, W. T., Luo, L., Fan, C. W., Tang, D. M., Zhao, Y., Luo, J. Z., Wang, F. X., Li, M. S., & Wang, H. S. (2026). Novel norditerpene-phenanthrenes from Selaginella effusa inhibit T24 cell proliferation via blockade of the TRPV1/ STAT3/NF-κB pathway. Fitoterapia. https://doi.org/10.1016/j.fitote.2025.106986
Vancouver
Sun WT, Luo L, Fan CW, Tang DM, Zhao Y, Luo JZ, et al. Novel norditerpene-phenanthrenes from Selaginella effusa inhibit T24 cell proliferation via blockade of the TRPV1/ STAT3/NF-κB pathway. Fitoterapia. 2026. doi:10.1016/j.fitote.2025.106986
BibTeX
@article{Sun2026,
author = {Sun, Wen-Tao and Luo, Li and Fan, Cai-Wen and Tang, De-Min and Zhao, Yi and Luo, Jia-Zi and Wang, Fang-Xin and Li, Mei-Shan and Wang, Heng-Shan},
title = {Novel norditerpene-phenanthrenes from Selaginella effusa inhibit T24 cell proliferation via blockade of the TRPV1/ STAT3/NF-κB pathway},
journal = {Fitoterapia},
year = {2026},
doi = {10.1016/j.fitote.2025.106986}
}
EUVIMED